bisoprolol has been researched along with Left Sided Breast Cancer in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators." | 2.90 | Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy : Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014). ( Becherini, C; Bonomo, P; Calusi, S; Casati, M; Delli Paoli, C; Desideri, I; Francolini, G; Greto, D; Livi, L; Loi, M; Meattini, I; Olmetto, E; Pallotta, S; Pezzulla, D; Terziani, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francolini, G | 1 |
| Desideri, I | 1 |
| Meattini, I | 1 |
| Becherini, C | 1 |
| Terziani, F | 1 |
| Olmetto, E | 1 |
| Delli Paoli, C | 1 |
| Pezzulla, D | 1 |
| Loi, M | 1 |
| Bonomo, P | 1 |
| Greto, D | 1 |
| Calusi, S | 1 |
| Casati, M | 1 |
| Pallotta, S | 1 |
| Livi, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial[NCT02236806] | Phase 3 | 262 participants (Actual) | Interventional | 2015-07-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bisoprolol and Left Sided Breast Cancer
| Article | Year |
|---|---|
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy : Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014).
Topics: Algorithms; Bisoprolol; Cardiotonic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug | 2019 |